Date : 02 April 2026

Centralize your Pharmaceutical Manufacturing Market intelligence and stay ahead - Buy Now.
| Company | Description |
| Pfizer | A firm is a key player to offer the cardiovascular drug Eliquis and the Prevnar vaccine family. |
| Johnson & Johnson | Its offerings focus on oncology and immunology, with products such as Darzalex and Stelara.  |
| AbbVie | It is a popular firm for Humira (immunology) & also strengthened its portfolio with Botox, Venclexta, and Vraylar. |
| Merck & Co. | This prominently explores its oncology blockbuster Keytruda, and is a center in vaccines & animal health. |
| Roche | A company specializes in oncology & specialized diagnostics, with expansion into neuroscience. |
| AstraZeneca | This facilitates diverse pharmaceuticals in oncology, cardiovascular, renal, & metabolic treatments. |
| Novartis | A leader explores novel medicine in cardiovascular, renal, and metabolic, oncology, immunology, and also neurosciences. |
| Bristol Myers Squibb | Its offerings include small molecule drugs, biologics, and CAR T-cell therapies, specializing in oncology, hematology, immunology, and cardiovascular diseases. |
| GSK | It has a robust portfolio in vaccines and specialty medicines, specifically in respiratory, HIV, oncology, and immunology. |
| Sanofi | This provides drugs for immunological, neurological, oncological, and rare diseases, with extensive vaccine production. |
The global pharmaceutical manufacturing market size was estimated at USD 616.19 billion in 2025 and is predicted to increase from USD 652.67 billion in 2026 to approximately USD 1095.2 billion by 2035, expanding at a CAGR of 5.92% from 2026 to 2035.

R&D
Formulation and Final Dosage Preparation
Patient Support & Services
Speak with a healthcare analyst about your research, consulting, or platform needs.